Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Tau, a molecular modulator of neuronal energy managment

EnergizeTau

"The intraneuronal somatodendritic ""missorting"" and aggregation of Tau are pathological hallmarks in neurodegenerative diseases (NDDs) like and Alzheimer's disease (AD), and are thought to be drivers of neurotoxicity. That NDDs manifesting with Tau ""missorting"" present with (neuro)metabolic abnormalities, often prior to pathology onset, is...

Funding Programme
Start Date
End Date
Total Funding
€ 2 194 940
European Countries Involved

Technology driven self-management for building resilience among people with early stage cognitive impairment

Resilien-T

Many elderly people suffer from one or another Mild Cognitive Impairment (PwMCI). Among many is forgetfulness which may or may not progress to dementia. They are faced with doubt, worry and diminishing self-worth while often being afraid to look for help. We will develop RESILIEN-T to act as a coach to improve the PwMCI self-management in different...

Funding Programme
Start Date
End Date
Total Funding
€ 0
European Countries Involved

Terahertz Ultra Strong Coupling for mAcromolecules structure aNalYse & control

TUSCany

MacroMolecules (e.g Proteins, DNA) carry out most of the functions of the living and these functions come from their 3D-structure. For instance, foldopathy like Alzheimers and Parkinsons disease are caused by misfolding of proteins. Modifying this structure non-invasively is consequently a tremendous challenge for both microbiology research and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 555
European Countries Involved

The biofabrication of a 3D in vitro human oviduct model to study infertility and factors affecting embryo development

OviChip

Despite being viewed as a simple transport conduit, the oviduct can determine a successful pregnancy and has a life-long impact on our health and wellbeing. Also called the fallopian tube, our understanding of tubal function remains limited, owing to the ethical limitations of human studies and the poor translations of animal studies to people. The...

Funding Programme
Start Date
End Date
Total Funding
€ 2 318 530
European Countries Involved

The Brain Health Toolbox: Facilitating personalized decision-making for effective dementia prevention

Brain Health Toolbox

Preventing dementia and Alzheimer disease (AD) is a global priority. Previous single-intervention failures stress the critical need for a new multimodal preventive approach in these complex multifactorial conditions. The Brain Health Toolbox is designed to create a seamless continuum from accurate dementia prediction to effective prevention by i)...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 268
European Countries Involved

The chemistry and physics of RNP granules: how they form, age and cause disease

PhaseAge

Recent studies suggest that defective ribonucleoprotein (RNP) granules and altered RNA processing cause neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, defective RNP granules only develop late in life, suggesting that young cells have mechanisms in place to prevent their...

Funding Programme
Start Date
End Date
Total Funding
€ 1 931 303
European Countries Involved

The contribution of thalamocortical projections to high cognitive functions (speech processing, working memory and attention) in sighted and unsighted populations

THALABLIND

The proposed project aims to investigate the contribution of thalamocortical projections to high cognitive functions such as speechprocessing, working memory and attention in sighted and unsighted populations. In the last decades, advances made in magneticresonance imaging (MRI) have shed light on the cortical regions subserving these processes...

Funding Programme
Start Date
End Date
Total Funding
€ 181 152
European Countries Involved

THE DEVELOPMENT OF NOVEL PHOTOSWITCHABLE KINASE INHIBITORS

RET PHOTOSWITCH

The overall research objective of this project is to develop novel photoswitchable kinase inhibitors (PKIs), targeting on REarrange during Transfection (RET) for use in living cells and in zebrafish (Danio rerio). Controlling the action of kinases in a reversible way will have an exceptional potential for investigating signal transduction in...

Funding Programme
Start Date
End Date
Total Funding
€ 185 857
European Countries Involved

The EEG Dementia Index – Fast and Affordable Dementia Diagnosis

BTD

Dementia is a devastating neurodegenerative disease that causes tremendous suffering for patients and their families. The disease’s relentless progression leads to a loss of all mental abilities, making patients completely dependent on constant care and supervision. Even though the disease is incurable, there are treatments available that can...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

The effect of pro-aging and pro-youthful blood factors in normal ageing and Alzheimer’s disease: a multimodal approach

BioALFA

The overall aim of the planned research is to test whether pro-aging and pro-youthful blood factors are associated with cognitive performance and neuroimaging outcomes in normal ageing and in individuals at risk of Alzheimer’s disease (AD), and whether this association is modified by lifestyle habits (e.g. exercise or diet) or genetic factors...

Funding Programme
Start Date
End Date
Total Funding
€ 158 122
European Countries Involved

The effects of an extensive exercise program on the progression of mild cognitive impairment (MCI)

NEUROEXERCICE

Epidemiological studies have shown that leisure-time physical activity at midlife is associated with a decreased risk of dementia later in life. Although initial studies indicate enhanced behavioural performance in dementia patients after three months of exercise, little is known about the effect of an extensive, controlled and regular exercise...

Funding Programme
Start Date
End Date
Total Funding
€ 1 395 100
European Countries Involved

The Ethics of Loneliness and Sociability

Ethics of Loneliness

Loneliness, which can be defined as the negative mental states (e.g. sadness, despair) that people experience when they feel that they do not have enough relationships, or not the right kinds of relationships, is a widespread phenomenon in many societies. Even prior to the current pandemic, surveys from Europe and North-America reported that 20 to...

Funding Programme
Start Date
End Date
Total Funding
€ 1 025 860
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).